Seovigo Pharvis medicine treats cerebral and peripheral disorders (10 blisters x 10 tablets)

Dosage form Film bag tablets
Specifications Box of 10 blisters x 10 tablets
Ingredient High dry ginkgo leaves
Indication Memory impairment, brain circulation disorders, headache, Alzheimer, dizziness, tooth loss
Contraindication Blood coagulation disorders

Ingredient

Thành phần cho 1 viên

Composition information	Content
High dry ginkgo leaves	80mg

Uses

indications

Seovigo Pharvis 10x10 is indicated in the following cases:

Treatment of cerebral and peripheral disorders (limp). Flavonol Glycosid shows the inhibition of platelet collection, and shows the effect of "cleaning free radicals". It seems that it also inhibits the production of histamine and leukotrien. It also shows the ability to inhibit muscarin -type effect on cholinocceptor and 2 - Adrenoceptor. It may change the properties of blood flow. European ginkgo products sold in the form of EGB 761 have shown the stimulating effect on the vestibular nuclear neurons (LVN) and in-Vitro and In-Vivocho studies that increase the Synap's acquisition of 5-hydroxytryptamine.

This drug also shows the blockage of ascorbic/Fe2+ acid, causing a decrease in the movement of the Synap body membrane. "The previous occupation of neuron lipid lipid is caused by ascorbic/Fe2+ acid along with the relief of the moving province of the membrane, which reduces the ability to transport dopamine to collect dopamine."

Ginkgo Biloba extract (ginkgo) slow down the consumption of O2 (exertion) of irritated cells by inhibiting NADPH - OXID, enzymes responsible for O2 decomposition to O2+. As a result, the production of Superoxid (O2) and Hydrogen Peroxyd (H2O2) is significantly reduced when PMNS stimulation is made in the presence of drugs at concentrations of 500, 250 and 125 mcg/ml. Moreover, the generation of hydroxy (OH-) roots is greatly reduced at low concentrations of 15.6 mcg gbe/ml, which shows that the extract also has the activity of cleaning free radicals, GBE is likely to at least significantly reduce the activity of myeloperoxidase in neutrophils.

Dynamic pharmacokinetics

on animals, after taking extracts with carbon 14, studying the absorption and distribution of the drug shows the rapid and complete absorption. The radioactive balance in 72 hours shows the release in CO2 exhaled and in the urine.

Measurement of radioactivity in the blood over time creates pharmacokinetic parameters and shows the biological destruction time of about 4 hours and 30 minutes.

Radioactive peak in the blood is reached after 1 hour and 30 minutes, the absorption occurs in the upper part of the digestive tract.

Research on the distribution of radioactive tissue shows the affinity of the eye and some types of nodes and nerves, especially the hypothalamus and the pattern.

Ginkgolid A's bioavailability is recorded in humans of 98 - 100%, Ginkgolid B is 79 - 93% and bilobalid is over 70% or more.

A study of 12 volunteers showed that after taking a single dose high, the ginkgo dose of 0.90 - 3.36 mg while hungry stomachs showed high levels of bioavailability. This level is represented by the average values (+/- sd) of the bioavailability coefficient (FAUC) with values of 0.8 (+/- 0.09), 0.88 (+/ 0.21) and 0.79 (+/- 0.30) corresponding to Ginkgolid A, Ginkgolid B, and Bilobalid.

Food does not change AUC value but increases Tmax.

LD50 in mice, LD50 is 7725 mg/kg, the drug is used by oral 2 times a day. Therefore, toxicity is considered very low.

Before taking Seovigo Pharvis medicine treats cerebral and peripheral disorders (10 blisters x 10 tablets)

How to use

Seovigo Pharvis 10x10 is used orally, should be taken during or after meals.

Dosage

peripheral circulatory disorders, dizziness, tinnitus: 1 tablet/day.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose?

What to do when you forget a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Seovigo Pharvis 10x10, you may experience unwanted effects (ADR).

Rare, 1/10000

Muscle muscle: headache.

digestive: discomfort to the stomach area. Systemic: Fever, chills and shock.

Very rare, ADR

Digestive: mild digestive disorders.

Systemic: allergies. Cardiovascular: circulatory disorders (reduce blood pressure, dizziness, headache, tachycardia). Neurological: Insomnia. skin: skin allergies.

Instructions on how to handle ADR

Notify the doctor with unwanted effects when using the drug.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Seovigo Pharvis 10x10 contraindications in the following cases:

Patients with hypersensitivity to the extract is Ginkgo or any ingredient of the drug.

Children under 12 years old.

Do not replace drugs to treat hypertension, not for myocardial, brain, brain hemorrhage, people with bleeding (coagulation disorders).

Caution when using

Pregnant women.

Do not use instead of medication to treat hypertension, not for myocardial, brain, brain hemorrhage.

The ability to drive and operate machinery

The drug can cause dizziness, headache, affecting the ability to drive and operate machinery. Therefore, be careful for patients to do these jobs.

Pregnancy

Safe crystal when used for pregnant women is not known. Dovigo Pharvis 10x10 should not be used for pregnant women.

The period of breastfeeding

Should not be used in breastfeeding women because Seovigo Pharvis 10x10 is excreted through breast milk or not.

Drug interactions

Do not use Ginkgo Biloba (ginkgo) with an Aspirin pain medicine, Ticlid brain complications, Persartin. Do not use Ginkgo Biloba combination with anticoagulant drugs, anti -platelet gathering drugs, blood indicator.

Storage

Store in closed packaging, avoid light, avoid moisture, temperature below 30 ° C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.